Company / EPS (Basic)
PALVELLA THERAPEUTICS, INC. EPS (Basic) History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$7.83
FY2024
5-year range
-$7.83 / -$0.45
FY2021-FY2024
Trend
-1640.0%
vs FY2023
Sector context
#197 of 208
Health Care
What the data says
EPS (Basic) changed -1640% YoY in FY2024, a notable deviation from the 3-year average annual change of -536%.
Based on SEC 10-K filings.
-7.83 in FY2024.
Declined from $-0.71 to $-7.83 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 208This company -$7.83 Sector average -$0.96
▼
-713.0% below sector average
Key checks
Key Insights
- In FY2024, eps (basic) decreased 1640.0% year-over-year.
- Ranks #197 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$7.83 | -1640.0% |
| FY2023 | -$0.45 | +36.6% |
| FY2022 | -$0.71 | -4.4% |
| FY2021 | -$0.68 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026